Contract drug maker Catalent to double production of Moderna COVID vaccine: WSJ

Catalent Inc. , a contract drug manufacturer, is expanding U.S. production of the COVID-19 vaccine developed by Moderna Inc. and will nearly double production at its Bloomington, Ind. plant to about 400 vials a minute in April, the Wall Street Journal reported Tuesday, citing people familiar with the matter.